Is IVVD Worth Buying in 2026?

Invivyd, Inc. Common Stock

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-07-26

Here’s whether Invivyd, Inc. Common Stock (IVVD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-13.58% over 10 days); RSI 28 — oversold; weak 1-year return of -24.5%; 3-month momentum negative (-58.1%). Currently 80.1% off its 52-week high. Score: -7/7.

Ready to act on this? 📈 Trade on Webull

IVVD is trading below its 200-day MA ($1.65) — a key warning sign the longer-term trend is under pressure. An RSI of 28.2 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -24.5% compares to +16.5% for SPY (trailed the market by 41.0%). The current 80.1% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $7,548 today
vs. S&P 500 (SPY) — same period trailed market by 41.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.65)
Above 50-day MA ($0.94)
!RSI(14) neutral zone (30–70) — currently 28.2
Positive return (-24.5%)
!Within 10% of period high (−80.1%)
Period Range $0.61
$0.48 $3.07
RSI (14) 28.2
0 · OversoldOverbought · 100

Key Metrics

Price$0.61
Period Return-24.5%
Period High$3.07
Period Low$0.48
Drawdown−80.1%
MA-50$0.94
MA-200$1.65
RSI (14)28.2
Avg Volume (30d)5.7M
vs. SPYtrailed by 41.0%
Return Rank#730 of 999

Trade IVVD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers